Categories
Pancreatic Cancer

Amplia Therapeutics achieves critical clinical milestone for lead cancer therapy [Video]

Amplia Therapeutics Ltd CEO and managing director Dr John Lambert speaks with Proactive’s Andrew Scott about its clinical trial of focal adhesion kinase (FAK) inhibitor AMP945 for the treatment of patients with advanced pancreatic cancer.AMP945 use is intended to increase the efficacy of gemcitabine/nab-paclitaxel chemotherapy for people with advanced pancreatic cancer undergoing first-line treatment.

Categories
Brain Cancer

NATO use of depleted uranium during 1999 bombing of Yugoslavia leaves Serbia 97,000 cancer patients [Video]

People’s Daily: Today marks the 23rd anniversary of the end of NATO’s bombing of the Federal Republic of Yugoslavia. After an international legal team filed lawsuits against NATO on behalf of 3,000 victims over the horrific consequences of up to 15 tons of depleted uranium bombs NATO dropped in 1999, NATO responded by saying it has immunity from prosecution. Do you have any comment?Zhao Lijian: Twenty-three years ago, US-led NATO blatantly bombarded the Federal Republic of Yugoslavia for 78 days without the approval of the UN Security Council. In total, NATO dropped nearly 420,000 bombs weighing 22,000 tons, including 15 tons of depleted uranium bombs. Over 2,500 people including 79 children were killed and more than one million people became refugees as a direct result of the bombings. What is more heart-wrenching is that death and agony brought by the war lingered for generations till this day. As noted by experts, exposure to radiation emitted by depleted uranium bombs can show no symptom for years and depleted uranium bombs have long-term impact on the environment and human food-chain. In the 10 years after the bombing, about 30,000 people in Serbia developed cancer, among whom 10,000 died. According to the Institute of Public Health of Belgrade, by the end of 2019, the number of registered cancer patients in Serbia was as high as 97,000. A study of the Serbian emergency center shows that among children born in Serbia after 1999, many aged between one and five suffered from ectodermal tumors, many aged between five and nine contracted hematological malignancies, and there is a clear uptick in the morbidity rate of brain cancer among those aged between nine and 18. Besides, by May 2019, 366 Italian military personnel who participated in the NATO military operations have died of cancer, and 7,500 have fallen sick. However, till this day, the US — the country that sent military aircraft to drop depleted uranium bombs over Serbia and the inventor of this type of bombs as well as the only country that has ever used them — continues to deny that depleted uranium bombs can directly cause Gulf War syndrome and Kosovo syndrome. During the Gulf War, the US dropped far more depleted uranium bombs over Iraq. NATO is also trying to get away with it by claiming immunity from prosecution. Such moves by the US-led NATO are shocking. Neither the Serbian people, nor people elsewhere in the world seeking justice, will ever agree to this. The US-led NATO should earnestly reflect on its war crimes, and provide a reasonable explanation and compensations to the victims of depleted uranium bombs as soon as possible. NATO must also seriously learn the lesson and stop creating new turmoil and division across the world. __________________Powered by Shanghai Media Group, ShanghaiEye focuses on producing top-quality content for Facebook, Twitter, Instagram and Youtube.Nobody knows Shanghai better than us.Please subscribe to us ☻☻☻__________________For more stories, please click ■ What’s up today in Shanghai, the most updated news of the cityhttps://www.youtube.com/playlist?list=PLeyl7CQ2A5MNjpE4hspSVry8dR555getN■ Amazing Shanghai, exploring the unknown corners of the city, learning the people, food and stories behind themhttps://www.youtube.com/playlist?list=PLeyl7CQ2A5MMVTWr-zIXjsS4hhSQPmyes■ What Chinese people’s lives are like during the post COVID-19 periodhttps://www.youtube.com/playlist?list=PLeyl7CQ2A5MPrPTmIirpfgETu6VKVESXe■ Views of foreign scholars on China and its affairshttps://www.youtube.com/playlist?list=PLeyl7CQ2A5MO9ua_nSK6slRPdUl-ovjRe■ Foreign faces in Shanghai, people living in this city sharing their true feelingshttps://www.youtube.com/playlist?list=PLeyl7CQ2A5MP0vJDSw23_1MCPJhAfGbiG■ Mini-docs showing why China is the country it is today https://www.youtube.com/playlist?list=PLeyl7CQ2A5MOreRu2AbZ3ziIUyCcdBLwX__________________☎Leave us messages if you have any suggestions or questions!Thank you!

Categories
Blood Cancer

HOPE Putin dies! Putin ‘very ill with blood cancer’ claims Russian oligarch [Video]

#Uknews #UKnewsTime HOPE Putin dies! Putin ‘very ill with blood cancer’ claims Russian oligarch.VLADIMIR PUTIN is “very ill with blood cancer”, a Russian oligarch has reportedly claimed in an audio recording.Speculation surrounding the Russian leader’s health has been widespread since he ordered the invasion of Ukraine. Kremlin spokesperson Dmitry Peskov has attempted to bat away queries on the president’s health, saying he remains in “excellent” physical shape.But in a recording obtained by New Lines Magazine, a high-profile Russian oligarch claimed Putin is “very ill with blood cancer”.The outlet reported that it chose to keep the identity of the oligarch anonymous for his safety, and that he was unaware he was being recorded.✔ Uk News Time Thank you for watching my video! Please subscribe to our UK News Time channel to get more updates from the British and support us more and more. Website: http://uknewstime.net/© Copyright by UK News Time ☞ Do not Reup © Copyright all rights reserved.

Categories
Pediatric Cancer

Kazia Therapeutics Ltd wraps up a busy quarter presenting paxalisib data at the AACR annual meeting [Video]

Kazia Therapeutics Ltd’s James Garner tells Andrew Scott about the company’s quarterly achievements, including data the company presented at the American Association of Cancer Research (AACR) conference on the use of its asset paxalisib in a rare, aggressive childhood cancer. It has been a busy quarter for the company on the trials front, and news for investors is good too, with the company introducing an at-the-market financing facility in the US – a quick and efficient way of transacting on biotech shares.

Categories
Pancreatic Cancer

Amplia Therapeutics gets trial green light, initiates toxicology studies in March quarter [Video]

Amplia Therapeutics’ Dr John Lambert speaks to Proactive about the company’s March quarter, which saw the company receive an ethics green light to proceed with a phase two pancreatic cancer trial. The healthcare stock also initiated some key toxicology studies for its lead drug candidate, AMP945, which will open the door to other therapeutic areas beyond the cancer space. Dr Lambert says all the pieces are in place for the phase two AMP945 clinical trial, and the company is now preparing to recruit patients for the study.

Categories
Pancreatic Cancer

Amplia free to proceed with phase two pancreatic cancer trial [Video]

Amplia Therapeutics’ Dr John Lambert walks investors through the latest news on the company’s AMP945 drug candidate, which just secured ethics clearance for a phase two trial in pancreatic cancer patients. Dr Lambert says the green light represented the company’s last hurdle, and the trial is now free to proceed with recruitment. It looks like the first patient will be dosed in April or May in New South Wales.